Paik, Kwang Yeol <br/><br/>
Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.  [electronic resource] 

 -  Hepatobiliary & pancreatic diseases international : HBPD INT  Apr 2016 
 - 158-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1499-3872 
<br/><br/><label>Standard No.: </label>10.1016/s1499-3872(15)60042-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Hepatocellular--pathology<br/>Cell Survival<br/>Chemoembolization, Therapeutic--adverse effects<br/>Chemotherapy, Adjuvant<br/>Chi-Square Distribution<br/>Disease-Free Survival<br/>Female<br/>Hepatectomy--adverse effects<br/>Humans<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--pathology<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoadjuvant Therapy--adverse effects<br/>Neoplasm Recurrence, Local<br/>Neoplasm Staging<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Risk Assessment<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome